RIKEN TECHNOS CORPORATION
4220・Prime Market・Chemicals
Governance
The company has adopted the Audit and Supervisory Committee structure and appoints independent outside directors accounting for one-third or more of the board. Through an executive officer system, it separates decision-making and oversight functions from business execution functions, and both the Nomination Committee and the Compensation Committee are composed of a majority of independent outside directors.
Risk Management
The Risk & Compliance Committee, chaired by the President, centrally manages risks across the group, confirming progress on countermeasures and reviewing them on a semi-annual basis. Climate change risk is addressed through collaboration between the Sustainability Committee and the Risk & Compliance Committee, which jointly formulate and monitor countermeasures.
Shareholder Returns
Annual dividend for FY2026 (ending March 2026) is ¥54 per share (interim ¥20 + year-end ¥34), an increase of ¥13 year-on-year. Consolidated payout ratio is 35.1%. The forecast for FY2027 (ending March 2027) maintains ¥54 (forecast payout ratio of 37.8%). Share buybacks of ¥4,572 million were conducted, keeping the total shareholder return ratio at a high level.
Dividend Policy
The basic policy is to pay stable dividends with a target consolidated payout ratio of around 35%, while taking into account future business investment and the strengthening of shareholders' equity. Dividends are paid twice a year, at the interim period-end (September 30) and fiscal year-end (March 31). The consolidated payout ratio for FY2026 (ending March 2026) is 35.1%, and the forecast payout ratio for FY2027 (ending March 2027) is 37.8%.
ESG
Sustainability is positioned as a pillar of management in the three-year Medium-Term Management Plan, targeting a 46.2% reduction in CO2 emissions (non-consolidated Scope 1 and 2) by 2030 compared to FY2019, and Group carbon neutrality by 2050. The company has established a wide range of materiality items and KPIs covering human capital development, DE&I, respect for human rights, and health management, among others, with the Board of Directors overseeing progress on a quarterly basis.
Last updated: June 10, 2026